Status:

TERMINATED

Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin

Lead Sponsor:

University Hospital, Grenoble

Conditions:

Obstructive Sleep Apnea Syndrome

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

The aim of this clinical trial is to evaluate the effect of Atorvastatin on the endothelial function improvement during the obstructive sleep apnea syndrome (OSAS) after 3 months of treatment, by a do...

Detailed Description

Secondary objectives of this clinical trial : * To evaluate the effect of Atorvastatin in comparison with the placebo on the inflammation occurring during OSAS, after 3 months of treatment. * To eval...

Eligibility Criteria

Inclusion

  • Men or women \> 18 years old
  • Subjects diagnosed with OSAS (apnea/hypopnea index = AHI \> 30/h)
  • Subjects with clinical ATH from grade I or II controlled with mono-therapy(140\<SAP\<180 mmHg and 90\<DAP\<110 mmHg)

Exclusion

  • Patients with a history of prior stroke or coronary ischemic disease
  • Chronic respiratory disease (PaO2 \< 60 mmHg and/or PaCO2 \> 45 mmHg)
  • Lung disease
  • Hypothyroidism
  • Statin treatment
  • Antihypertensive treatment with more than one drug
  • Pregnant or lactating women
  • Alcohol consumption \> 3 units/day
  • Treatment by itraconazole, ketoconazole, antiprotease, fibrates, antivitamin K, diltiazem, verapamil, erythromycin, clarithromycin, cyclosporin.
  • Hypersensitivity to one of the drug compounds
  • Patients with modified concomitant treatments during the 3 months before inclusion
  • Potentially dangerous sleepiness
  • Jobs at risk

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2013

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT00669695

Start Date

May 1 2008

End Date

February 1 2013

Last Update

September 24 2013

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Universitary Hospital of Angers

Angers, France, 49033

2

Hospital of Annemasse

Annemasse, France, 74017

3

University Hospital of Grenoble

Grenoble, France, 38043

4

Universitary Hospital of Geneva

Geneva, Switzerland, 1211

Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin | DecenTrialz